Furthermore, DNMT3A-mutated AML cells exhibit resistance to macrophage-mediated killing and can differentiate into monocyte-like cells with immunosuppressive properties, further contributing to the inhibition of effective anti-leukemic T cell responses (62). This evidence concerns the gene DNMT3A and acute myeloid leukemia.